What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2022-11-14 compared with 2022-08-03 · 44 added, 62 removed, 6 unchanged (95% of the section changed)

1 unchanged sentence

following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Agreement, dated October 26, 2021, by and between the Company and I-Bankers Securities, Inc., as representative of the several underwriters

(incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the Commission on November

Combination Marketing Agreement, dated October 26, 2021, by and between the Company and I-Bankers Securities, Inc.

(incorporated

by reference to Exhibit 1.2 to the Company’s Current Report on Form 8-K filed with the Commission on November 1, 2021).

Combination Agreement dated July 12, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet

Motor (USA) Company, Inc.

and the Sellers named therein (incorporated by reference to Exhibit 2.1 to the Company’s Current

Report on Form 8-K filed with the Commission on July 18, 2022).

of Correction to the Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s

Current Report on Form 8-K filed with the Commission on November 4, 2021).

(incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 (File No.

333-259500) filed with

the Commission on September 13, 2021).

Agreement, dated October 26, 2021, by and between the Company and American Stock Transfer & Trust Company, LLC, as rights agent

(incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Commission on November

Agreement, dated October 26, 2021, by and among the Company, its officers, its directors, Bright Vision Sponsor LLC and I-Bankers

Securities, Inc.

(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission

on November 1, 2021).

Management Trust Agreement, dated October 26, 2021, by and between the Company and American Stock Transfer & Trust Company, LLC,

(incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Commission

on November 1, 2021).

Rights Agreement, dated October 26, 2021, by and among the Company and certain security holders.

(incorporated by reference to Exhibit

10.3 to the Company’s Current Report on Form 8-K filed with the Commission on November 1, 2021).

Placement Units Purchase Agreement, dated October 26, 2021, by and among the Company, Bright Vision Sponsor LLC and I-Bankers Securities,

(incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Commission on November

Agreement dated July 12, 2022, among Deep Medicine Acquisition Corp., Bright Vision Sponsor LLC, Chijet Inc.

and Chijet Motor Company,

(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on July

of Lock-Up Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the

Commission on July 18, 2022).

of Amended and Restated Registration Rights Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report

on Form 8-K filed with the Commission on July 18, 2022).

Certification

of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section

302 of the Sarbanes-Oxley Act of 2002

Certification

of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section

302 of the Sarbanes-Oxley Act of 2002

Certification

of Principal Executive Officer Pursuant to 18 U.S.C.

Amendment No.

1 to Business Combination Agreement, dated September 6, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc.

and the Sellers named therein (holding in excess of 50% of Chijet’s outstanding shares) (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 12, 2022).

Amendment No.

2 to Business Combination Agreement, dated September 16, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc.

and the Sellers named therein (holding in excess of 50% of Chijet’s outstanding shares).

(incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 20, 2022).

Business Combination Agreement, dated July 12, 2022, among Deep Medicine Acquisition Corp., Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc.

and the Sellers named therein (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed on July 18, 2022).

Support Agreement dated July 12, 2022, among Deep Medicine Acquisition Corp., Bright Vision Sponsor LLC, Chijet Inc.

and Chijet Motor Company, Inc.

(incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on July 18, 2022).

Form of Promissory Note issued on October 15, 2022.

(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 20, 2022).

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Executive Officer Pursuant to 18 U.S.C.

Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Certification

of Principal Financial Officer Pursuant to 18 U.S.C.

Certification of Principal Financial Officer Pursuant to 18 U.S.C.

Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

XBRL Instance Document

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Labels Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Page Interactive Data File.

of the exhibits, appendices, annexes and/or schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2).

The Registrant agrees to furnish supplementally a copy of all omitted exhibits, annexes, appendices and schedules to the Securities

and Exchange Commission upon its request.

Inline XBRL Instance Document